Literature DB >> 26857573

Mice with Genetic Deletion of Group VIA Phospholipase A2β Exhibit Impaired Macrophage Function and Increased Parasite Load in Trypanosoma cruzi-Induced Myocarditis.

Janhavi Sharma1, Jennifer R Blase2, Daniel F Hoft2, John O Marentette1, John Turk3, Jane McHowat4.   

Abstract

Trypanosoma cruzi infection, which is the etiological agent of Chagas disease, is associated with intense inflammation during the acute and chronic phases. The pathological progression of Chagas disease is influenced by the infiltration and transmigration of inflammatory cells across the endothelium to infected tissues, which are carefully regulated processes involving several molecular mediators, including adhesion molecules and platelet-activating factor (PAF). We have shown that PAF production is dependent upon calcium-independent group VIA phospholipase A2β (iPLA2β) following infection of human coronary artery endothelial cells (HCAECs) with T. cruzi, suggesting that the absence of iPLA2β may decrease the recruitment of inflammatory cells to the heart to manage parasite accumulation. Cardiac endothelial cells isolated from iPLA2β-knockout (iPLA2β-KO) mice infected withT. cruzi demonstrated decreased PAF production compared to that by cells isolated from wild-type (WT) mice but demonstrated increases in adhesion molecule expression similar to those seen in WT mice. Myocardial inflammation in iPLA2β-KO mice infected with T. cruzi was similar in severity to that in WT mice, but the iPLA2β-KO mouse myocardium contained more parasite pseudocysts. Upon activation, macrophages from iPLA2β-KO mice produced significantly less nitric oxide (NO) and caused lessT. cruzi inhibition than macrophages from wild-type mice. Thus, the absence of iPLA2β activity does not influence myocardial inflammation, but iPLA2β is essential forT. cruzi clearance.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26857573      PMCID: PMC4807476          DOI: 10.1128/IAI.01564-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  ECG detection of murine chagasic cardiomyopathy.

Authors:  Christopher S Eickhoff; Cade T Lawrence; John E Sagartz; Leesa A Bryant; Arthur J Labovitz; Simil S Gala; Daniel F Hoft
Journal:  J Parasitol       Date:  2010-08       Impact factor: 1.276

2.  Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.

Authors:  O K Giddings; C S Eickhoff; T J Smith; L A Bryant; D F Hoft
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4.

Authors:  Chunyan Tan; Robert Day; Shunzhong Bao; John Turk; Qingwei David Zhao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-30       Impact factor: 8.311

Review 4.  The therapeutic potential of phospholipase A2 inhibitors in cardiovascular disease.

Authors:  M C White; J McHowat
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

Review 5.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 6.  Role of platelet-activating factor in cardiovascular pathophysiology.

Authors:  G Montrucchio; G Alloatti; G Camussi
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

7.  Genetic and pharmacologic evidence that calcium-independent phospholipase A2beta regulates virus-induced inducible nitric-oxide synthase expression by macrophages.

Authors:  Jason M Moran; R Mark L Buller; Jane McHowat; John Turk; Mary Wohltmann; Richard W Gross; John A Corbett
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

8.  Novel role for calcium-independent phospholipase A(2) in the macrophage antiviral response of inducible nitric-oxide synthase expression.

Authors:  Leonard B Maggi; Jason M Moran; Anna L Scarim; David A Ford; Ji-Won Yoon; Jane McHowat; R Mark L Buller; John A Corbett
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

9.  Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors--how to make a dream come true.

Authors:  Joseli Lannes-Vieira; Jaline Coutinho Silverio; Isabela Resende Pereira; Nathália Ferreira Vinagre; Cristiano Marcelo Espinola Carvalho; Cláudia Neto Paiva; Andréa Alice Silva da
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

10.  iPLA2beta: front and center in human monocyte chemotaxis to MCP-1.

Authors:  Ravi S Mishra; Kevin A Carnevale; Martha K Cathcart
Journal:  J Exp Med       Date:  2008-01-21       Impact factor: 14.307

View more
  4 in total

Review 1.  iPLA2β and its role in male fertility, neurological disorders, metabolic disorders, and inflammation.

Authors:  John Turk; Tayleur D White; Alexander J Nelson; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-11-05       Impact factor: 4.698

2.  Multi-omics Analysis of Liver Infiltrating Macrophages Following Ethanol Consumption.

Authors:  John O Marentette; Meng Wang; Cole R Michel; Roger Powell; Xing Zhang; Nichole Reisdorph; Kristofer S Fritz; Cynthia Ju
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

Review 3.  The Impact of the Ca2+-Independent Phospholipase A2β (iPLA2β) on Immune Cells.

Authors:  Tayleur D White; Abdulaziz Almutairi; Ying Gai Tusing; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biomolecules       Date:  2021-04-15

Review 4.  Rescue of Hepatic Phospholipid Remodeling Defectin iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver.

Authors:  Walee Chamulitrat; Chutima Jansakun; Huili Li; Gerhard Liebisch
Journal:  Biomolecules       Date:  2020-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.